Jose Ignacio Andres Gil

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jose Ignacio Andres Gil. Retrieved from https://idiyas.com/inventor/jose-ignacio-andres-gil-9aydkb0h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 75.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 9.7

ph-index = 4

Forward Citations = 61(Granted Patents)

Company Filing History:

12 out of 2,101

Janssen Pharmaceutica Nv

patents

Years Active: 2015-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338243 - P2X7 modulators (2025-06-24),

2. 12247027 - P2X7 modulators (2025-03-11),

3. 11820770 - P2X7 modulators (2023-11-21),

4. 11225478 - P2X7 modulators (2022-01-18),

5. 10703749 - P2X7 modulators (2020-07-07),

6. 10323032 - P2X7 Modulators (2019-06-18),

7. 10150765 - P2X7 modulators (2018-12-11),

8. 10112937 - P2X7 modulators and methods of use (2018-10-30),

9. 9604982 - P2X7 modulators (2017-03-28),

10. 9464084 - P2X7 modulators (2016-10-11),

11. 9096596 - P2X7 modulators (2015-08-04),

12. 9066946 - P2X7 modulators (2015-06-30),

Title: Jose Ignacio Andres Gil: Innovator in Pharmaceutical Compounds

Introduction

Jose Ignacio Andres Gil is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate the P2X7 receptor. With a total of 12 patents to his name, his work has the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents, Jose has developed P2X7 modulators, which are directed to compounds of Formula (I). These compounds include enantiomers and diastereomers, and the invention also encompasses pharmaceutical compositions comprising these compounds. Additionally, he has worked on another set of P2X7 modulators, which are directed to compounds of Formulas (I, IIa, and IIb). This invention also relates to pharmaceutical compositions and methods of making and using these compounds.

Career Highlights

Jose Ignacio Andres Gil is currently associated with Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical sector. His expertise in developing novel compounds has positioned him as a key player in the industry.

Collaborations

Jose has collaborated with notable colleagues, including Michael Anthony Letavic and Manuel Jesus Alcazar Vaca. These partnerships have further enhanced his research and development efforts.

Conclusion

Jose Ignacio Andres Gil is a distinguished inventor whose work in pharmaceutical compounds is paving the way for new therapeutic options. His contributions to the field are noteworthy and continue to influence the landscape of medical innovation.

Profile summary based on public USPTO records.